Literature DB >> 6321545

Large-scale serological screening for cytomegalovirus antibodies in homosexual males by enzyme-linked immunosorbent assay.

J S Dylewski, L Rasmussen, J Mills, T C Merigan.   

Abstract

We compared an enzyme-linked immunosorbent assay (ELISA) with complement fixation and radioimmunoassay in determining the presence of immunoglobulin antibodies to cytomegalovirus. Of an initial 93 serum samples tested, the correlation between ELISA and radioimmunoassay was 98.9% and that between ELISA and complement fixation was 96.1%. ELISA was used to screen 1,123 homosexual men in San Francisco. Of 479 men attending a homosexual health fair, 35 (7%) lacked cytomegalovirus antibodies by ELISA. Only 15 (2%) of 644 homosexual men attending a municipal sexually transmitted disease clinic were found to be seronegative. All but one of the seronegatives detected by ELISA were also seronegative by radioimmunoassay and complement fixation. We conclude that ELISA can be used to reliably perform large-scale screening for the presence of immunoglobulin G antibodies to cytomegalovirus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321545      PMCID: PMC271018          DOI: 10.1128/jcm.19.2.200-203.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Comparison of enzyme-linked immunosorbent assay (ELISA) technique and complement-fixation test for estimation of cytomegalovirus IgG antibody.

Authors:  J C Booth; G Hannington; T A Aziz; H Stern
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

2.  Rapid detection of IgG and IgM antibodies for cytomegalovirus by the enzyme linked immunosorbent assay (ELISA).

Authors:  R Cappel; F de Cuyper; J de Braekeleer
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

3.  The respective advantages of complement fixation and ELISA for routine diagnosis of cytomegalovirus infection.

Authors:  B Pozzetto; O G Gaudin
Journal:  Biomedicine       Date:  1981-11

4.  Cytomegalovirus (CMV) antibody in male homosexuals: a source for CMV immune globulin.

Authors:  H Ikram; A M Prince; L N Baker
Journal:  Vox Sang       Date:  1983-03       Impact factor: 2.144

5.  Immunologic abnormalities in homosexual men. Relationship to Kaposi's sarcoma.

Authors:  R E Stahl; A Friedman-Kien; R Dubin; M Marmor; S Zolla-Pazner
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

6.  Enzyme-immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccination.

Authors:  A Voller; D E Bidwell
Journal:  Br J Exp Pathol       Date:  1976-04

7.  Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody.

Authors:  J C Booth; G Hannington; T M Bakir; H Stern; H Kangro; P D Griffiths; R B Heath
Journal:  J Clin Pathol       Date:  1982-12       Impact factor: 3.411

8.  Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus.

Authors:  L Rasmussen; D Kelsall; R Nelson; W Carney; M Hirsch; D Winston; J Preiksaitis; T C Merigan
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226

9.  Enzyme-linked immunosorbent assay for measurement of antibody against cytomegalovirus and rubella virus in a single serum dilution.

Authors:  A M van Loon; J T van der Logt; J van der Veen
Journal:  J Clin Pathol       Date:  1981-06       Impact factor: 3.411

10.  Prevalence of cytomegalovirus infection in homosexual men.

Authors:  W L Drew; L Mintz; R C Miner; M Sands; B Ketterer
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

  10 in total
  8 in total

1.  Epidemiological assessment of continuing transmission of lymphatic filariasis in Samoa.

Authors:  H Joseph; F Maiava; T Naseri; U Silva; P Lammie; W Melrose
Journal:  Ann Trop Med Parasitol       Date:  2011-12

2.  Latex agglutination and enzyme-linked immunosorbent assays for cytomegalovirus serologic screening of transplant donors and recipients.

Authors:  S W Chou; K M Scott
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

3.  Comparison of a latex agglutination test with five other methods for determining the presence of antibody against cytomegalovirus.

Authors:  D G Beckwith; D C Halstead; K Alpaugh; A Schweder; D A Blount-Fronefield; K Toth
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

4.  Rapid quantitation of cytomegalovirus and assay of neutralizing antibody by using monoclonal antibody to the major immediate-early viral protein.

Authors:  S W Chou; K M Scott
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

5.  Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients.

Authors:  S Chou; D Y Kim; K M Scott; D L Sewell
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

Review 6.  Nonpulmonary manifestations of cytomegalovirus infection in immunocompromised patients.

Authors:  W L Drew
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

7.  Application of the Filariasis CELISA Antifilarial IgG(4) Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific.

Authors:  Hayley Joseph; Fuatai Maiava; Take Naseri; Fasihah Taleo; Malakai 'ake; Corinne Capuano; Wayne Melrose
Journal:  J Trop Med       Date:  2011-09-26

8.  Investigation of Mixture Modelling Algorithms as a Tool for Determining the Statistical Likelihood of Serological Exposure to Filariasis Utilizing Historical Data from the Lymphatic Filariasis Surveillance Program in Vanuatu.

Authors:  Hayley Joseph; Sarah Sullivan; Peter Wood; Wayne Melrose; Fasihah Taleo; Patricia Graves
Journal:  Trop Med Infect Dis       Date:  2019-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.